Current Report Filing (8-k)
January 30 2017 - 5:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
FORM 8-K
_______________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): January 24, 2017
OrangeHook, Inc.
(Exact name of Registrant as Specified in
its Charter)
Florida
|
|
000-54249
|
|
27-1230588
|
(State or Other Jurisdiction of Incorporation or Organization)
|
|
(Commission file number)
|
|
(I.R.S. Employer Identification Number)
|
319 Barry Avenue South #300
Wayzata, Minnesota 55391
(Address of Principal Executive Offices
including Zip Code)
(442) 500-4665
(Registrant’s Telephone Number,
including Area Code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1 Entry into a Material Definitive
Agreement
On January 24, 2017, OrangeHook, Inc. (the
“
Company
”), LifeMed ID, Inc., a wholly owned subsidiary of the Company (“
LifeMed
”), and Lenovo
HK Limited (“
Lenovo
”) entered into Amendment 1 (the “
Amendment
”) to the Business Partner
Agreement dated as of March 10, 2016 (the “
Agreement
”).
Under the Agreement, Lenovo bundles
certain LifeMed software with Lenovo hardware that Lenovo provides to third party end users in exchange for monthly service
fees, and LifeMed is entitled to a portion of such fees. Among other changes to the mechanics of implementing the arrangement
under the Agreement, the Amendment provides that Lenovo will pay LifeMed its portion of the fees upfront upon entrance into
agreements with end users, which will be subject to a true-up by LifeMed for any monthly fees that are not
subsequently paid by the end user. In addition, as part of the Amendment, the Company has agreed to guarantee the obligations
of LifeMed under the Agreement.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
OrangeHook, Inc.
|
|
|
|
|
|
Date: January 30, 2017
|
By:
|
/s/ James Mandel
|
|
|
James Mandel
|
|
|
President and Chief Executive Officer
|